Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major threat to treatment success and hence alternate less toxic therapies are warranted. NF-E2 related factor-2 (Nrf2), a master regulator of antioxida...
Saved in:
| Main Authors: | Sreeja Karathedath, Bharathi M Rajamani, Syed Mohammed Musheer Aalam, Ajay Abraham, Savitha Varatharajan, Partha Krishnamurthy, Vikram Mathews, Shaji Ramachandran Velayudhan, Poonkuzhali Balasubramanian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177227&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24
by: Miriam Sánchez-Ortega, et al.
Published: (2025-07-01) -
The emerging role of Nrf2 in dermatotoxicology
by: Nguan S Tan, et al.
Published: (2014-02-01) -
Advance in Nrf2 Signaling Pathway in Leishmaniasis
by: Sarmistha Saha, et al.
Published: (2024-11-01) -
The Nrf2-HO-1 system and inflammaging
by: Sinead A. O’Rourke, et al.
Published: (2024-09-01) -
Effect of new water-soluble phenolic antioxidants on the activity of Nrf2-driven enzymes, glutathione system, and Nrf2 translocation into the nucleus
by: E. B. Menshchikova, et al.
Published: (2020-12-01)